Biologic Medicines in Gastroenterology - FOI Response Register

1. How many patients were treated in the last 3 months by the Gastroenterology department (for any medical condition) with the following biologic drugs:

• Adalimumab – Humira       

2

• Adalimumab Biosimilar      

11

• Filgotinib      

0                     

• Golimumab

0                     

• Infliximab – Remicade

0         

• Infliximab Biosimilar

2         

• Ozanimod     

0                     

• Tofacitinib    

0                     

• Upadacitinib

0                     

• Ustekinumab

2                     

• Vedolizumab

0 – I have assumed this is the infusion              

• Vedolizumab Injections ONLY (pre-filled pens or syringes)

2  

2. Does your trust participate in clinical trials for the treatment of Ulcerative Colitis? If so, please provide the total number of patients taking part in any Ulcerative Colitis study.

No